Andrew Lloyd

Andrew R. Lloyd, MB BS Syd, MD UNSW, FRACP, is an infectious diseases physician, and an epidemiology, virology and immunology researcher. He is a professor at the School of Medical Sciences, University of New South Wales, Sydney, Australia.

Awards

 * Member, Order of Australia (A.M): “For service to medicine and the community, particularly through provision of hepatitis services in prisons, and research in infectious diseases”

Clinic

 * The Fatigue Centre, Newtown, New South Wales, Australia, was created and is supervised by Dr. Andrew Lloyd to serve patients with CFS and post-cancer fatigue.

Book Chapters

 * 2005, "Fatigue states following infection," in Infectious Diseases A clinical approach, edn. 2
 * 1999, "Chronic fatigue syndrome: current concepts of pathogenesis and treatment," in Current Clinical Topics in Infectious Diseases, edn. Original

Notable studies

 * 2014, Gene Expression in Response to Exercise in Patients with Chronic Fatigue Syndrome: A Pilot Study FULL TEXT
 * 2006, Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: Prospective cohort study"'Abstract -To delineate the risk factors, symptom patterns, and longitudinal course of prolonged illnesses after a variety of acute infections. Prospective cohort study following patients from the time of acute infection with Epstein-Barr virus (glandular fever), Coxiella burnetii (Q fever), or Ross River virus (epidemic polyarthritis). The region surrounding the township of Dubbo in rural Australia, encompassing a 200 km geographical radius and 104,400 residents. 253 patients enrolled and followed at regular intervals over 12 months by self report, structured interview, and clinical assessment. Detailed medical, psychiatric, and laboratory evaluations at six months to apply diagnostic criteria for chronic fatigue syndrome. Premorbid and intercurrent illness characteristics recorded to define risk factors for chronic fatigue syndrome. Self reported illness phenotypes compared between infective groups. Prolonged illness characterised by disabling fatigue, musculoskeletal pain, neurocognitive difficulties, and mood disturbance was evident in 29 (12%) of 253 participants at six months, of whom 28 (11%) met the diagnostic criteria for chronic fatigue syndrome. This post-infective fatigue syndrome phenotype was stereotyped and occurred at a similar incidence after each infection. The syndrome was predicted largely by the severity of the acute illness rather than by demographic, psychological, or microbiological factors. A relatively uniform post-infective fatigue syndrome persists in a significant minority of patients for six months or more after clinical infection with several different viral and non-viral micro-organisms. Post-infective fatigue syndrome is a valid illness model for investigating one pathophysiological pathway to chronic fatigue syndrome.'"
 * 2006, Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus FULL TEXT
 * 2006, Prolonged Illness after Infectious Mononucleosis Is Associated with Altered Immunity but Not with Increased Viral Load FULL TEXT
 * 2003, Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution

Talks & interviews

 * 1-2 September 2014, UK CFS/ME Research Collaborative Conference - Talk title: "Acute infection & post-infective fatigue as a model for CFS"
 * 22 April 2014, [https://www.youtube.com/watch?v=BgWgX5F5WUM

Online presence

 * UNSW bio page

Learn more

 * 2015, "The Decline and Fall of an ME/CFS Researcher? the Case of Andrew Lloyd" by Cort Johnson for Heath Rising
 * 2012, "Model of Post Infective Fatigue Forming: the Dubbo Studies" in Phoenix Rising